Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions.
Abby E RudolphFarid L KhanTanya G SinghSrinivas Rao ValluriLaura A PuzniakJohn M McLaughlinPublished in: Infectious diseases and therapy (2024)
Most patients filled their nirmatrelvir/ritonavir prescriptions. Interventions to improve uptake should focus on increasing patient and provider awareness, reducing nirmatrelvir/ritonavir prescribing disparities, and ensuring treatment initiation within 5 days.